Filing Details

Accession Number:
0001562180-21-002544
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-01 20:35:09
Reporting Period:
2021-04-01
Accepted Time:
2021-04-01 20:35:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1517022 Akebia Therapeutics Inc. AKBA Pharmaceutical Preparations (2834) 208756903
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1776024 Dell Faulkingham C/o Akebia Therapeutics, Inc.
245 First Street
Cambridge MA 02142
Svp, Cco No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-04-01 952 $3.40 137,025 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.